Bank of America
BIO icon

Bank of America’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bank of America’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,200
Closed -$907K – 8259
2021
Q4 		$907K Buy
+1,200
New +$898K ﹤0.01% 5382

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Bank of America's BIO Position: Q1 2026 in Review

Bank of America reduced its Bio-Rad Laboratories Class A (BIO) stake by 0.11% in Q1 2026, selling an estimated $142K and leaving 444,957 shares worth $124M. The position accounts for 0.01% of the portfolio, ranked #971.

Bank of America first reported a position in BIO in Q2 2013 and has held it in 52 quarters since. The position peaked at $285M in Q3 2021. 393 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Bank of America held 444,957 shares of Bio-Rad Laboratories Class A worth $124M as of Q1 2026.
  • Bank of America sold 492 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $142K.
  • Bio-Rad Laboratories Class A made up 0.01% of Bank of America's portfolio in Q1 2026, its #971 holding.
  • Bank of America first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Bio-Rad Laboratories Class A position peaked at $285M in Q3 2021.
  • 393 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.